Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 08/17/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Kehinde Adekola MD,MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN NHLBI Data and Safety Monitoring Board (DSMB) |
None | None | None | 07/22/2022 |
| Larry Anderson, Jr. PhD,MD | AbbVie, Inc. Amgen Inc. Bristol-Myers Squibb Company Cellectar GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Prothena |
AbbVie, Inc. BeiGene Bristol-Myers Squibb Company Celgene Corporation Cellectar GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides Prothena sanofi-aventis U.S. |
AbbVie, Inc. BeiGene Bristol-Myers Squibb Company Celgene Corporation Cellectar GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides sanofi-aventis U.S. |
None | 07/25/2022 |
| Muhamed Baljevic MD | None | None | Bristol-Myers Squibb Company Cardinal Health CurioScience Janssen Biotech, Inc. Karyopharm Therapeutics NCCN 2020 Virtual Congress: Hematologic Malignancies Oncopeptides Inc. Sanofi-Genzyme |
None | 04/28/2022 |
| Ryan Berardi MSc | None | None | None | None | 06/27/2022 |
| Marian Birkeland PhD | None | None | None | None | 07/25/2022 |
| Natalie Callander MD | None | None | None | None | 12/26/2021 |
| Erica Campagnaro MD | None | None | None | None | 03/11/2022 |
| Jorge Castillo MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Pharmacyclics TG Therapeutics |
AbbVie, Inc. BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | 05/05/2022 |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Janssen Pharmaceutica Products, LP Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | 07/11/2022 |
| Eileen Cucinotta | None | None | None | None | 06/13/2022 |
| Christopher D'Angelo MD | BeiGene Bristol-Myers Squibb Company |
TG Therapeutics | TG Therapeutics | None | 03/22/2022 |
| Srinivas Devarakonda MD | None | None | None | None | 07/28/2022 |
| Sarah DeVincenzo BCPS,PharmD | None | None | None | None | 08/11/2022 |
| Noura Elsedawy MD | None | Janssen Pharmaceutica Products, LP | None | Vyriad | 03/21/2022 |
| Colleen Erb MSN,CRNP,AOCNP | None | None | None | None | 08/10/2022 |
| Alfred Garfall MD | CRISPR Therapeutics Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
Amgen Inc. Janssen Pharmaceutica Products, LP Legend Bio |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | 06/06/2022 |
| Kelly Godby MD | None | None | None | None | 03/17/2022 |
| Kristina Gregory OCN,MSN,RN | None | None | None | None | 08/15/2022 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 06/13/2022 |
| Jens Hillengass MD,PhD | Amgen Inc. Bristol-Myers Squibb Company Gilead Sciences, Inc. GlaxoSmithKline HARPOON Janssen Pharmaceutica Products, LP Pfizer Inc. sanofi-aventis U.S. |
Aptitude Health GlaxoSmithKline Intellisphere Janssen Pharmaceutica Products, LP Oncopeptides sanofi-aventis U.S. Skyline |
Amgen Inc. BeiGene Beijing Medical Award Foundation Curio Science Patient Partners Rapid Payer Response Research to Practice |
None | 08/11/2022 |
| Leona Holmberg PhD,MD | Bristol-Myers Squibb Company Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | 07/18/2022 |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP |
None | None | None | 05/26/2022 |
| Carol Ann Huff MD | Glenmark / Ichnos Prothena |
GlaxoSmithKline Oncopeptides sanofi-aventis U.S. |
None | None | 04/06/2022 |
| Malin Hultcrantz PhD,MD | Amgen Inc. Daiichi- Sankyo Co. GlaxoSmithKline |
GlaxoSmithKline | Bristol-Myers Squibb Company | None | 04/13/2022 |
| Yubin Kang MD | None | None | None | None | 12/05/2021 |
| Rashmi Kumar PhD | None | None | None | None | 03/04/2022 |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Carsgen GlaxoSmithKline MedImmune Inc. Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. BeiGene Bluebird Bristol-Myers Squibb Company Epizyme GlaxoSmithKline GLH Pharma Oncopeptides Pfizer Inc. Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Secura Takeda Pharmaceuticals North America, Inc. Trillium |
None | None | 05/23/2022 |
| Sarah Larson MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Pfizer Inc. sanofi-aventis U.S. |
1200 Pharma TORL Biotherapeutics |
None | None | 04/21/2022 |
| Hans Lee MD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP National Cancer Institute Regeneron Pharmaceuticals, Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. GlaxoSmithKline Immunitis Therapeutics Karyopharm Therapeutics Legend Biotech Monte Rosa Therapeutics Oncopeptides Pfizer Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | 05/26/2022 |
| Michaela Liedtke MD | Allogene Bristol-Myers Squibb Company Caelum Celgene Corporation Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Adaptive Janssen Pharmaceutica Products, LP Natera |
None | None | 07/04/2022 |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GlaxoSmithKline | None | None | 11/08/2021 |
| John Murphy | None | None | None | None | 08/10/2022 |
| James Omel MD | None | None | None | None | 07/25/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 06/21/2022 |
| Aaron Rosenberg MD | Cerecor GlaxoSmithKline Kangpu Biopharmaceuticals |
None | Takeda Pharmaceuticals North America, Inc. | None | 02/19/2022 |
| Douglas Sborov MD,MSc | AbbVie, Inc. Amgen Inc. Bristol-Myers Squibb Company Gilead Sciences, Inc. GlaxoSmithKline Janssen Pharmaceutica Products, LP Pfizer Inc. sanofi-aventis U.S. |
AbbVie, Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP sanofi-aventis U.S. |
AbbVie, Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP sanofi-aventis U.S. |
None | 05/23/2022 |
| Attaya Suvannasankha MD | NA | NA | NA | NA | Pending |
| Jason Valent MD | AbbVie, Inc. Alexion Pharmaceuticals, Inc. Allogene therapeutics Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Pfizer Inc. Pharmacyclics Prothena Biosciences |
AbbVie, Inc. | Bristol-Myers Squibb Company | none | 04/25/2022 |